SO
BIO icon

STRS Ohio’s Bio-Rad Laboratories Class A BIO Stock Holding History

STRS Ohio’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
383
-60
-14% -$17K ﹤0.01% 1836
2026
Q1 		$123K Hold
443
– – ﹤0.01% 1704
2025
Q4 		$134K Sell
443
-4
-0.9% -$1.25K ﹤0.01% 1709
2025
Q3 		$125K Sell
447
-16
-3% -$4.35K ﹤0.01% 1762
2025
Q2 		$112K Buy
+463
New +$109K ﹤0.01% 1829
2022
Q2 		– Sell
-6,091
Closed -$3.43M – 2056
2022
Q1 		$3.43M Buy
6,091
+1,879
+45% +$1.13M 0.01% 547
2021
Q4 		$3.18M Buy
4,212
+533
+14% +$399K 0.01% 571
2021
Q3 		$2.74M Sell
3,679
-422
-10% -$316K 0.01% 580
2021
Q2 		$2.64M Sell
4,101
-911
-18% -$554K 0.01% 641
2021
Q1 		$2.86M Sell
5,012
-163
-3% -$96.5K 0.01% 593
2020
Q4 		$3.02M Buy
5,175
+213
+4% +$121K 0.01% 588
2020
Q3 		$2.56M Sell
4,962
-343
-6% -$174K 0.01% 585
2020
Q2 		$2.4M Buy
5,305
+2,914
+122% +$1.29M 0.01% 583
2020
Q1 		$838K Sell
2,391
-968
-29% -$356K ﹤0.01% 798
2019
Q4 		$1.24M Buy
3,359
+2,000
+147% +$705K 0.01% 800
2019
Q3 		$452K Buy
1,359
+250
+23% +$81.6K ﹤0.01% 1335
2019
Q2 		$346K Sell
1,109
-126
-10% -$37.7K ﹤0.01% 1504
2019
Q1 		$377K Sell
1,235
-575
-32% -$155K ﹤0.01% 1439
2018
Q4 		$420K Buy
1,810
+13
+0.7% +$3.49K ﹤0.01% 1346
2018
Q3 		$562K Buy
1,797
+677
+60% +$210K ﹤0.01% 1321
2018
Q2 		$323K Buy
+1,120
New +$309K ﹤0.01% 1587

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

STRS Ohio's BIO Position: Q2 2026 in Review

STRS Ohio reduced its Bio-Rad Laboratories Class A (BIO) stake by 14% in Q2 2026, selling an estimated $17K and leaving 383 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1836.

STRS Ohio first reported a position in BIO in Q2 2018 and has held it in 21 quarters since. The position peaked at $3.43M in Q1 2022. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • STRS Ohio held 383 shares of Bio-Rad Laboratories Class A worth $112K as of Q2 2026.
  • STRS Ohio sold 60 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $17K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1836 holding.
  • STRS Ohio first reported a position in Bio-Rad Laboratories Class A in Q2 2018 and has held it in 21 quarters since.
  • STRS Ohio's Bio-Rad Laboratories Class A position peaked at $3.43M in Q1 2022.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.